Author details

Full Name

Dirk Foell

Affiliation

ORCID

Career Start Year

2002

Papers

207

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37291093	Incident psoriasis under treatment with tumor necrosis factor-Î± inhibitors in juvenile idiopathic arthritis patients-analysis of the BiKeR registry.		2023
36222562	Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survival.	Rheumatology	2023
36409585	Aberrant Naive CD4-Positive T Cell Differentiation in Systemic Juvenile Idiopathic Arthritis Committed to B Cell Help.	Arthritis and Rheumatology	2023
37759792	Patients with Systemic Juvenile Idiopathic Arthritis (SJIA) Show Differences in Autoantibody Signatures Based on Disease Activity.		2023
37752496	Treat-to-target strategies for the management of familial Mediterranean Fever in children.		2023
37923864	Treatment of systemic juvenile idiopathic arthritis.		2023
37878193	A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings.		2023
37786243	Type 1 Interferon-Stimulated Gene Expression and Disease Activity in Pediatric Rheumatic Diseases: No Composite Scores Needed?		2023
37212859	Dysregulation of miRNA-30e-3p targeting IL-1Î² in an international cohort of systemic autoinflammatory disease patients.	J Mol Med (Berl)	2023
37023943	Inflammatory Biomarkers Can Differentiate Acute Lymphoblastic Leukemia with Arthropathy from Juvenile Idiopathic Arthritis Better Than Standard Blood Tests.		2023
37066963	Phagocyte-related S100 proteins and cytokines in acute lymphoblastic leukemia and their prognostic value.		2023
37046303	Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis - data from a German Inception cohort.		2023
36530128	Association Between HLA-DPB1 and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Children.		2023
35325053	Soluble interleukin-2 receptor serum levels facilitate prediction of relapses in subgroups of patients with juvenile idiopathic arthritis.	Rheumatology	2022
35699824	An Immunological Axis Involving Interleukin 1Î² and Leucine-Rich-Î±2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial.	J Clin Immunol	2022
35623638	The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated period	Annals of the Rheumatic Diseases	2022
35621220	The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Period	Arthritis and Rheumatology	2022
35368387	Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study.	Lancet Rheumatology, The	2022
35486225	Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.	Clin Rheumatol	2022
36130012	IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.	New England Journal of Medicine	2022
35413850	Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients.	Journal of Neuroinflammation	2022
35260388	Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial.	Annals of the Rheumatic Diseases	2022
34559193	MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever.	Rheumatology (Oxford)	2022
34559194	miR-23a contributes to T cellular redox metabolism in juvenile idiopathic oligoarthritis.	Rheumatology	2022
35109858	Prevalence of autoantibodies in patients with juvenile idiopathic arthritis: results from the German inception cohort ICON-JIA.	Pediatric Rheumatology	2022
34939314	Patient parameters and response after administration of rituximab in pediatric mature B-cell non-Hodgkin lymphoma.	Pediatric Blood and Cancer	2022
34640417	Distinct Effects of Interleukin-1Î² Inhibition upon Cytokine Profile in Patients with Adult-Onset Still's Disease and Active Articular Manifestation Responding to Canakinumab.	Journal of Clinical Medicine	2021
33752669	Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registry.	Pediatric Rheumatology	2021
34239010	A myostatin-CCL20-CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis.	Scientific Reports	2021
33692808	Different Disease Endotypes in Phenotypically Similar Vasculitides Affecting Small-to-Medium Sized Blood Vessels.	Front Immunol	2021
33576397	A dysregulated interleukin-18-interferon-Î³-CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis.	Rheumatology	2021
33892792	Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease.		2021
33880885	Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.	Arthritis and Rheumatology	2021
33933108	Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline.	Pediatric Rheumatology	2021
34131132	Lasp1 regulates adherens junction dynamics and fibroblast transformation in destructive arthritis.	Nat Commun	2021
33758351	Serum biomarkers confirming stable remission in inflammatory bowel disease.	Scientific Reports	2021
32514673	Impact of chorioamnionitis on maternal and fetal levels of proinflammatory S100A12.	European Journal of Pediatrics	2021
33165509	Impaired IFN-Î³-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients.	Inflammatory Bowel Diseases	2021
31049936	Refining the dermatological spectrum in primary immunodeficiency: mucosa-associated lymphoid tissue lymphoma translocation protein 1 deficiency mimicking Netherton/Omenn syndromes.	Br J Dermatol	2020
31599092	Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis.	Arthritis and Rheumatology	2020
31943968	Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long-Term Safety Data from the German BIKER Registry.	ACR Open Rheumatology	2020
32105591	Adherence to ophthalmological screening recommendations and course of uveitis in children with juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study.	Clin Exp Rheumatol	2020
31710506	Synergistic Signaling of TLR and IFNÎ±/Î² Facilitates Escape of IL-18 Expression from Endotoxin Tolerance.	Am J Respir Crit Care Med	2020
31560043	Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.	Inflammatory Bowel Diseases	2020
32477355	Increased Prevalence of Q703K Variant Among Patients With Autoinflammatory Diseases: An International Multicentric Study.	Frontiers in Immunology	2020
32444390	Cord Blood Low-Density Granulocytes Correspond to an Immature Granulocytic Subset with Low Expression of S100A12.	Journal of Immunology	2020
32655537	Gene-Dose Effect of Gain-of-Function Mutations Determines Neutrophil Activation in Familial Mediterranean Fever.	Frontiers in Immunology	2020
32821070	Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease.		2020
33013884	Case Report: Adult Still's Disease in an Alemtuzumab-Treated Multiple Sclerosis Patient.	Frontiers in Immunology	2020
32670276	The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice.	Frontiers in Immunology	2020